跳至主要内容
临床试验/NCT05785026
NCT05785026招募中不适用

Effectiveness and Mechanisms of Menthol Inhalation for the Relief of Dyspnea in Health and COPD

KU Leuven1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2023年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
KU Leuven
入组人数
120
试验地点
1
主要终点
Difference in respiratory-related evoked potentials (RREP) with menthol vs. strawberry.

研究概览

简要总结

Menthol inhalation (MI) is a novel and promising treatment option for acute relief of dyspnea, however, the underlying ventilatory and/or neural related mechanisms for this relief in symptoms remain unknown. The overall aim of this research project is to systematically examine the mechanisms of dyspnea relief from MI in healthy individuals and those with COPD.

详细描述

The project is structured in 5 work packages (WP), each including a different sample of healthy volunteers (WP1, 2) or patients with COPD (WP3, 4, 5), respectively with a 1:1 female/male ratio in each WP. Each WP will be single-blind, placebo-controlled cross-over trial to investigate the effects of MI compared to placebo in healthy volunteers during resistive loaded breathing (WP1), in healthy volunteers during cycling exercise (WP2), in people with COPD who have dyspnea at rest (WP3), and in people with COPD during cycling exercise (WP4, 5).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Age: 18 years of age or older
  • •Able to speak, read, and write Dutch or English
  • •Normal pulmonary function: forced expiratory volume in 1 second (FEV1) to forced vital capacity ratio>0.70; FEV1≥80%predicted (WP1 and 2 only)
  • •Non-smoker or former smokers (smoke-free ≥12 months prior to enrolment) (WP1 and 2 only)
  • •Clinically stable COPD (based on clinical judgment of the study physician that have not had exacerbations requiring escalation of medical therapy (i.e., short course of oral corticosteroids or antibiotics) within the preceding 14 days (WP3 and 4 only)

排除标准

  • •Contraindication to exercise testing (e.g., significant cardiovascular, musculoskeletal, neurological disease; see Table 4 from ERS/ATS consensus statement)
  • •Significant pulmonary or extra-pulmonary disease that, based on clinical assessment, could influence dyspnea and/or impair exercise capacity (with the exception of COPD in WP3 and 4)
  • •Body mass index <18.5 or >35 kg/m2
  • •An ulcer or tumor in the esophagus, a nasal septum deviation, or recent nasopharyngeal surgery
  • •Severe facial trauma including cribriform plate disruption (bone separating brain from nasal cavity)
  • •Allergies to latex and sensitivities to local anesthetics
  • •Inability to give informed consent, including those with significant cognitive impairment
  • •Alcohol consumption within 12 hours of study visit
  • •Current smoker*
  • •History of early menopause (age <45 years)
  • •Pregnancy or desire to become pregnant while in trial

研究组 & 干预措施

WP 3c

No Intervention

Resting breathing in dyspneic COPD participants.

WP 4a

Experimental

Menthol inhalation during cycle exercise in COPD participants.

干预措施: Menthol inhalation (Other)

WP 4b

Placebo Comparator

Strawberry scent during cycle exercise in COPD participants.

干预措施: Strawberry scent (Other)

WP 1a

Experimental

Menthol inhalation during resistive loaded breathing trials in healthy participants.

干预措施: Menthol inhalation (Other)

WP 1b

Placebo Comparator

Strawberry scent during resistive loaded breathing trials in healthy participants.

干预措施: Strawberry scent (Other)

WP 2a

Experimental

Menthol inhalation during cycle exercise in healthy participants.

干预措施: Menthol inhalation (Other)

WP 2b

Placebo Comparator

Strawberry scent during cycle exercise in healthy participants.

干预措施: Strawberry scent (Other)

WP 3a

Experimental

Menthol inhalation during resting breathing in dyspneic COPD participants.

干预措施: Menthol inhalation (Other)

WP 3b

Placebo Comparator

Strawberry scent during resting breathing in dyspneic COPD participants.

干预措施: Strawberry scent (Other)

WP 5a

Experimental

Menthol inhalation and facial airflow during cycle exercise in COPD participants

干预措施: Menthol inhalation and facial airflow (Other)

WP 5b

Placebo Comparator

Strawberry inhalation and airflow to leg during cycle exercise in COPD participants

干预措施: Strawberry scent and airflow to leg (Other)

WP 5c

Placebo Comparator

Menthol inhalation and airflow to leg during cycle exercise in COPD patients

干预措施: Menthol inhalation and airflow to leg (Other)

WP 5d

Placebo Comparator

Strawberry inhalation and facial airflow during cycle exercise in COPD patients

干预措施: Strawberry inhalation and facial airflow (Other)

结局指标

主要结局

Difference in respiratory-related evoked potentials (RREP) with menthol vs. strawberry.

时间窗: 1 week

RREPs will be measured using an electroencephalogram (EEG) sensor cap connected to a high-density 129 channel EEG system during breathing trials and exercise tests. Inspiration will briefly be interrupted for 150 milliseconds every two to six breaths by activation of the occluder, which induces the RREP in the EEG signal.

次要结局

未报告次要终点

研究者

发起方
KU Leuven
申办方类型
Other
责任方
Principal Investigator
主要研究者

Daniel Langer

Assistant Professor

KU Leuven

研究点 (1)

Loading locations...

相似试验